Skip to main content

Advertisement

Log in

Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rastogi T, Hildesheim A, Sinha R. Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer 2004;4:909–17

    Article  CAS  PubMed  Google Scholar 

  2. Bouvier AM, Remontet L, Jougla E et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol 2004;28:877–81

    Article  PubMed  Google Scholar 

  3. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999;86:158–69

    Article  CAS  PubMed  Google Scholar 

  4. Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496–502

    Article  CAS  PubMed  Google Scholar 

  5. Faivre J, Manfredi S, Bouvier AM. [Epidemiology of colorectal cancer liver metastases]. Bull Acad Natl Med 2003;187:815–22

    PubMed  Google Scholar 

  6. Yamamoto J, Shimada K, Kosuge T et al. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999;86:332–7

    Article  CAS  PubMed  Google Scholar 

  7. Minagawa N, Nakayama Y, Hirata K et al. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer. Anticancer Res 2002;22:2957–63

    CAS  PubMed  Google Scholar 

  8. Ercolani G, Grazi GL, Ravaioli M et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 2002;137:1187–92

    Article  PubMed  Google Scholar 

  9. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759–66

    Article  PubMed  Google Scholar 

  10. Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818–25

    Article  PubMed  Google Scholar 

  11. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 2004;139:1168–72

    Article  PubMed  Google Scholar 

  12. Adam R, Lucidi V, Bismuth H. Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am 2004;84:659–71

    Article  PubMed  Google Scholar 

  13. Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644–57

    Article  PubMed  Google Scholar 

  14. Adam R, Pascal G, Castaing D et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052–61

    Article  PubMed  Google Scholar 

  15. Fusai G, Davidson BR. Management of colorectal liver metastases. Colorectal Dis 2003;5:2–23

    Article  CAS  PubMed  Google Scholar 

  16. Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin 1999;49:231–55

    Article  CAS  PubMed  Google Scholar 

  17. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405–10

    Article  CAS  PubMed  Google Scholar 

  18. Giacchetti S, Itzhaki M, Gruia G et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663–9

    Article  CAS  PubMed  Google Scholar 

  19. Ong SY. Neoadjuvant chemotherapy in the management of colorectal metastases: A review of the literature. Ann Acad Med Singapore 2003;32:205–11

    CAS  PubMed  Google Scholar 

  20. Rougier P, Guimbaud R, Mitry E, Vaillant JN. [Chemotherapy with curative intent before (neoadjuvant) or after (adjuvant) surgery for colorectal cancer liver metastases]. Bull Acad Natl Med 2003;187:881–92

    PubMed  Google Scholar 

  21. Masi G, Allegrini G, Cupini S et al. First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule. Ann Oncol 2004;15:1766–72

    Article  CAS  PubMed  Google Scholar 

  22. Pozzo C, Basso M, Cassano A et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004;15:933–9

    Article  CAS  PubMed  Google Scholar 

  23. de Gramont A, Figer A, Seymour M et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938–47

    PubMed  Google Scholar 

  24. Rougier P, Van Cutsem E, Bajetta E et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998;352:1407–12

    Article  CAS  PubMed  Google Scholar 

  25. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 1997;350:681–6

    Article  CAS  PubMed  Google Scholar 

  26. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42

    Article  CAS  PubMed  Google Scholar 

  27. Cunningham D, Humblet Y, Siena S et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337–45

    Article  CAS  PubMed  Google Scholar 

  28. Rubio ED, Tabernero J, Cutsen EV et al. Cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer: An international phase II study. American Society of Clinical Oncology (ASCO) 2005; Abstract No: 3535

  29. Hoff PM, Eng C, Adinin RB et al. Preliminary results from a phase II study of FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer (mCRC) American Society of Clinical Oncology (ASCO) 2006; Abstract No: 252

  30. Folprecht G, Grothey A, Alberts S et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005;16:1311–9

    Article  CAS  PubMed  Google Scholar 

  31. Bismuth H, Adam R, Levi F et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509–20

    Article  CAS  PubMed  Google Scholar 

  32. Zelek L, Bugat R, Cherqui D et al. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann Oncol 2003;14:1537–42

    Article  CAS  PubMed  Google Scholar 

  33. Alberts SR, Horvath WL, Sternfeld WC et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 2005;23:9243–9

    Article  CAS  PubMed  Google Scholar 

  34. Karoui M, Penna C, Amin-Hashem M et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1–7

    Article  PubMed  Google Scholar 

  35. Vauthey JN, Pawlik TM, Ribero D et al. Chemotherapy regimen predicts steatohepatitis and an increase in ninety-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065–72

    Article  CAS  PubMed  Google Scholar 

  36. Elias D, Cavalcanti A, de Baere T et al. [Long-term oncological results of hepatectomy performed after selective portal embolization]. Ann Chir 1999;53:559–64

    CAS  PubMed  Google Scholar 

  37. Pawlik TM, Izzo F, Cohen DS et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003;10:1059–69

    Article  PubMed  Google Scholar 

  38. Adam R, Laurent A, Azoulay D et al. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777–85

    Article  CAS  PubMed  Google Scholar 

  39. Ijichi M, Makuuchi M, Imamura H, Takayama T. Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery 2001;130:116–8

    Article  CAS  PubMed  Google Scholar 

  40. Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996;223:77–83

    Article  CAS  PubMed  Google Scholar 

  41. Hirai I, Kimura W, Fuse A et al. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003;133:495–506

    Article  PubMed  Google Scholar 

  42. Vauthey JN, Chaoui A, Do KA et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000;127:512–9

    Article  CAS  PubMed  Google Scholar 

  43. Denys A, Madoff DC, Doenz F et al. Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy. Surg Oncol Clin N Am 2002;11:955–68

    Article  PubMed  Google Scholar 

  44. Soyer P, Roche A, Elias D, Levesque M. Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. Radiology 1992;184:695–7

    CAS  PubMed  Google Scholar 

  45. Heymsfield SB, Fulenwider T, Nordlinger B et al. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med 1979;90:185–7

    CAS  PubMed  Google Scholar 

  46. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001;88:165–75

    Article  CAS  PubMed  Google Scholar 

  47. Vauthey JN, Abdalla EK, Doherty DA et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002;8:233–40

    Article  PubMed  Google Scholar 

  48. Urata K, Kawasaki S, Matsunami H et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995;21:1317–21

    Article  CAS  PubMed  Google Scholar 

  49. Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: A meta-analysis. Liver Transpl 2005;11:1481–93

    Article  PubMed  Google Scholar 

  50. Vauthey JN, Pawlik TM, Abdalla EK et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004;239:722–32

    Article  PubMed  Google Scholar 

  51. Abdalla EK, Barnett CC, Doherty D et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675–80

    Article  PubMed  Google Scholar 

  52. Abdalla EK, Denys A, Chevalier P et al. Total and segmental liver volume variations: implications for liver surgery. Surgery 2004;135:404–10

    Article  PubMed  Google Scholar 

  53. Kooby DA, Fong Y, Suriawinata A et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7:1034–44

    Article  PubMed  Google Scholar 

  54. Behrns KE, Tsiotos GG, DeSouza NF et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292–8

    Article  CAS  PubMed  Google Scholar 

  55. Azoulay D, Castaing D, Krissat J et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000;232:665–72

    Article  CAS  PubMed  Google Scholar 

  56. Shirabe K, Shimada M, Gion T et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999;188:304–9

    Article  CAS  PubMed  Google Scholar 

  57. Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176–81

    CAS  PubMed  Google Scholar 

  58. Farges O, Belghiti J, Kianmanesh R et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003;237:208–17

    Article  PubMed  Google Scholar 

  59. de Baere T, Roche A, Vavasseur D et al. Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology 1993;188:73–7

    PubMed  Google Scholar 

  60. Capussotti L, Muratore A, Ferrero A et al. Extension of Right Portal Vein Embolization to Segment IV Portal Branches. Arch Surg 2005;140:1100–3

    Article  PubMed  Google Scholar 

  61. Nagino M, Nimura Y, Kamiya J et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995;117:677–81

    Article  CAS  PubMed  Google Scholar 

  62. Nagino M, Kamiya J, Kanai M et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery 2000;127:155–60

    Article  CAS  PubMed  Google Scholar 

  63. Madoff DC, Abdalla EK, Gupta S et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 2005;16:215–25

    PubMed  Google Scholar 

  64. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005;16:779–90

    PubMed  Google Scholar 

  65. Elias D, De Baere T, Roche A et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999;86:784–8

    Article  CAS  PubMed  Google Scholar 

  66. Kokudo N, Tada K, Seki M et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001;34:267–72

    Article  CAS  PubMed  Google Scholar 

  67. Abdalla EK, Smith DL, Madoff DC et al. Portal vein embolization of the entire tumor-bearing liver prior to major hepatectomy is not associated with significant tumor growth. HPB 2004;6:6 - Abstract No. 18

    Google Scholar 

  68. Madoff DC, Hicks ME, Abdalla EK et al. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness—study in 26 patients. Radiology 2003;227:251–60

    Article  PubMed  Google Scholar 

  69. Madoff DC. Portal vein embolization using polyvinyl alcohol and coils in preparation for major liver resection in patients with advanced hepatobiliary malignancy. J Vasc Interv Radiol 2001;12:S39

    Article  Google Scholar 

  70. Shoup M, Gonen M, D’Angelica M et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003;7:325–30

    Article  PubMed  Google Scholar 

  71. Cady B, Jenkins RL, Steele GD, Jr. et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998;227:566–71

    Article  CAS  PubMed  Google Scholar 

  72. Bowles BJ, Machi J, Limm WM et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864–9

    Article  CAS  PubMed  Google Scholar 

  73. Wood TF, Rose DM, Chung M et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593–600

    CAS  PubMed  Google Scholar 

  74. Bleicher RJ, Allegra DP, Nora DT et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003;10:52–8

    Article  PubMed  Google Scholar 

  75. Solbiati L, Livraghi T, Goldberg SN et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159–66

    Article  CAS  PubMed  Google Scholar 

  76. Jaeck D, Nakano H, Bachellier P et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 2002;9:430–8

    Article  PubMed  Google Scholar 

  77. Laurent C, Sa Cunha A, Couderc P et al. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 2003;90:1131–6

    Article  CAS  PubMed  Google Scholar 

  78. Elias D, Ouellet JF, Bellon N et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003;90:567–74

    Article  CAS  PubMed  Google Scholar 

  79. Elias D, Liberale G, Vernerey D et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005;12:900–9

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Nicolas Vauthey MD.

Additional information

Proceedings of the Consensus Conference sponsored by the American Hepato-Pancreato-Biliary Association and cosponsored by the Society for Surgery of the Alimentary Tract and the Society of Surgical Oncology, held in San Francisco, CA, USA, January 25, 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdalla, E.K., Adam, R., Bilchik, A.J. et al. Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement. Ann Surg Oncol 13, 1271–1280 (2006). https://doi.org/10.1245/s10434-006-9045-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9045-5

Keywords

Navigation